Abstract

AbstractThe title catalyst (H2IMes)[3,5‐NC5H3(CH2CH2Rf8)2]2(Cl)2Ru(=CHPh) [H2IMes=1,3‐bis(2,4,6‐trimethylphenyl)‐4,5‐dihydroimidazol‐2‐ylidene, Rf8=(CF2)7CF3] was prepared from the fluorous pyridine 3,5‐NC5H3(CH2CH2Rf8)2 (2.1 equiv.) and the pyridine complex (H2IMes)(NC5H5)2(Cl)2Ru(=CHPh). 3,5‐NC5H3(CH2CH2Rf8)2 was synthesized by a Heck reaction of 3,5‐dibromopyridine and the fluorous alkene H2C=CHRf8 [2.4 equiv.; Pd(OAc)2 (cat.), n‐Bu4N+ Br−/NaOAc (2.0 equiv.)], followed by hydrogenation. The catalyst shows dramatic rate accelerations in the ring‐closing metatheses of α,ω‐dienes under fluorous/organic liquid/liquid biphasic conditions [e.g., perfluoro(methyldecalin)/CD2Cl2] relative to rates under monophasic organic conditions (e.g., CD2Cl2). These catalysts require initial dissociation of the pyridine ligands to generate the active species, which can either combine with an alkene (productive) or recombine with a pyridine (unproductive). In the case of (H2IMes)[3,5‐NC5H2(CH2CH2Rf8)2]2(Cl)2Ru(=CHPh), fluorophilic 3,5‐NC5H3(CH2CH2Rf8)2 transfers to the fluorous phase, in accord with its CF3C6F11/toluene partition coefficient [93.9:6.1 vs. 39.8:60.2 for (H2IMes)[3,5‐NC5H3(CH2CH2Rf8)2]2(Cl)2Ru(=CHPh)], which decreases the fraction of unproductive events.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.